Aperture bio

Allston, United States

Aperture Bio provides a rapid, ultra-sensitive solution to quantify how, why and when drugs fail.

$150K raised

Oct 2023

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Aperture bio raised?

Aperture bio has raised $150K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2023.

Who are Aperture bio's investors?

Aperture bio's investors include Techstars, Merck Digital Sciences Studio.

Where is Aperture bio headquartered?

Aperture bio is headquartered in Allston, United States.

What does Aperture bio do?

Aperture Bio provides a rapid, ultra-sensitive solution to quantify how, why and when drugs fail.

What stage is Aperture bio at?

Aperture bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2023.

MLA

"Aperture bio — Funding & Investors." VCBacked, October 1, 2023, https://www.vcbacked.co/company/aperture-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). Aperture bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aperture-bio

Wikipedia (cite web)

{{cite web |title=Aperture bio — Funding & Investors |url=https://www.vcbacked.co/company/aperture-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2023.